Insmed Incorporated
INSM
$149.33
-$0.67-0.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.46% | -67.79% | -7.01% | -63.33% | -26.60% |
| Total Depreciation and Amortization | 127.78% | 58.25% | 48.43% | 12.73% | 0.14% |
| Total Amortization of Deferred Charges | -12.57% | -5.30% | -4.12% | -0.95% | -0.13% |
| Total Other Non-Cash Items | 1,666.19% | 158.35% | -24.41% | 140.91% | -85.19% |
| Change in Net Operating Assets | -233.86% | 188.34% | -75.89% | -19.88% | 266.65% |
| Cash from Operations | -26.34% | -21.47% | -67.19% | -42.41% | -49.81% |
| Capital Expenditure | -144.96% | 34.45% | 48.64% | -115.22% | -214.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.08% | 24.00% | -- | -69.84% | 3,401.77% |
| Cash from Investing | 195.55% | 24.04% | 3,458.91% | -72.77% | 7,207.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.12% | -13.53% | -318.14% | -13.69% | -158.83% |
| Issuance of Common Stock | 152.29% | -91.41% | 10.08% | 633.07% | -88.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.75% | -91.59% | 9.77% | 859.56% | 29.24% |
| Foreign Exchange rate Adjustments | 100.47% | -153.07% | 246.08% | 193.91% | -248.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.74% | -20.91% | 35.33% | -233.90% | 2,074.66% |